phone icon877-851-6164

25 Health Sciences Drive · Mailbox 107 · Stony Brook, NY 11790-3350 · USA

About Us

Vascular disease ultimately affects every organ in the human body. The treatment of vascular disease whether it involves the heart, brain, periphery and every other organ in the body has been steadily evolving from traditional surgery to more minimally invasive endovascular techniques. Advances in endovascular technology have already fundamentally altered the way we treat coronary artery disease, cerebral aneurysms, carotid stenosis, abdominal aortic aneurysms among numerous other disease processes.

Simultaneously, medical training of students, residents, fellows and physicians has been undergoing a transformation as the “see one, do one, teach one” model has become obsolete. The acquisition of good clinical judgement is derived from experience with difficult scenarios frequently resulting from complications during procedures and this experience is often preceded by poor clinical judgement. For surgeons, interventionists or any proceduralist there is a cost to acquiring a level of expertise that is considered mastery. This cost is the collateral damage in human quality of life.

A New Paradigm for Endovascular Training

Vascular Simulations LLC strives to reduce this collateral damage by physically replicating the vascular system from the heart to the aorta, cerebrovasculature and the peripheral vasculature. This replicator allows for the performance of endovascular procedures under real life fluoroscopic conditions with the actual access devices and implants that are utilized in clinical settings. It is fundamentally different than the current generation of endovascular simulators that model the performance and behavior of wires and catheters with computer software in a user interface that has no relevance to clinical procedures. These simulators are essentially glorified video games.

Vascular Simulations LLC is a limited liability company founded by Dr. Henry Woo MD, Michael Lockhart, Dr Baruch Lieber PhD, Dr David Fiorella MD PhD, Dr Chander Sadasivan PhD, and the Victoria Fund LLC. The manufacture of the replicators and all product development is accomplished at the Long Island Technology Incubator in Stony Brook, NY.

Management Team

The management team of Vascular Simulations consists of an experienced multi-disciplinary team of physicians, researchers, biomedical and mechanical engineers and entrepreneurs. The strength of the team lies in this unique blend of medical expertise, engineering creativity, and the ability to execute and reduce to practice.

Dr. Henry Woo, President/CEO

is the Director of the Cerebrovascular Center at SUNY Stony Brook. He obtained his medical degree from New York University and completed Neurosurgery residency and a fellowship in Interventional Neuroradiology at New York University Medical Center. He was the co-founder of Revasc Inc. which was ultimately acquired by Micrus Endovascular and Codman and Shurtleff, a division of Johnson and Johnson.

Dr. Barry Lieber, Chief Scientific Officer

is Professor of Neurosurgery and Biomedical Engineering at SUNY Stony Brook. Dr. Lieber received his PhD from Georgia Institue of Technology and is regarded as a leader in cerebrovascular biomedical engineering. He is currently the Director of the Cerebrovascular Research Center at SUNY Stony Brook. He was also a co-founder of Surpass Medical Ltd. which was acquired by Stryker Corporation.

Dr. David Fiorella, Chief Medical Officer

is the Director of Interventional Neuroradiology at SUNY Stony Brook. He obtained his medical degree from SUNY Buffalo. He completed his radiology residency at Duke University and his fellowships in Diagnostic and Interventional Neuroradiology at the Barrow Neurological Institute. He was the co-founder of Revasc Inc. which was ultimately acquired by Micrus Endovascular and Codman and Shurtleff a division of Johnson and Johnson.

Dr. Chander Sadasivan, Director of R & D

is a Research Scientist in Neurosurgery and Biomedical Engineering at SUNY Stony Brook. Dr. Sadasivan received his PhD from the University of Miami and is a leader in cerebrovascular biomedical engineering.